{
"instance": {
"etni-20191130.htm": {
"axisCustom": 0,
"axisStandard": 7,
"contextCount": 74,
"dts": {
"calculationLink": {
"local": [
"etni-20191130_cal.xml"
]
},
"definitionLink": {
"local": [
"etni-20191130_def.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
"http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
]
},
"inline": {
"local": [
"etni-20191130.htm"
]
},
"labelLink": {
"local": [
"etni-20191130_lab.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml",
"https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
]
},
"presentationLink": {
"local": [
"etni-20191130_pre.xml"
]
},
"referenceLink": {
"remote": [
"https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml"
]
},
"schema": {
"local": [
"etni-20191130.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
"https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
"https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
"https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
"https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
"https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
"https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
"https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
"https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
"http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
]
}
},
"elementCount": 207,
"entityCount": 1,
"hidden": {
"http://xbrl.sec.gov/dei/2019-01-31": 5,
"total": 5
},
"keyCustom": 28,
"keyStandard": 179,
"memberCustom": 8,
"memberStandard": 9,
"nsprefix": "etni",
"nsuri": "http://entb.net/20191130",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"strong",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:EntityRegistrantName",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "0001 - Document - Document and Entity Information",
"role": "http://entb.net/role/DocumentAndEntityInformation",
"shortName": "Document and Entity Information",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"strong",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"span",
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:EntityRegistrantName",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0010 - Disclosure - STOCKHOLDERS' EQUITY",
"role": "http://entb.net/role/StockholdersEquity",
"shortName": "STOCKHOLDERS' EQUITY",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:DeconsolidationOfZanderTherapeuticsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0011 - Disclosure - DECONSOLIDATION OF ZANDER THERAPEUTICS, INC.",
"role": "http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.",
"shortName": "DECONSOLIDATION OF ZANDER THERAPEUTICS, INC.",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:DeconsolidationOfZanderTherapeuticsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0012 - Disclosure - DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION",
"role": "http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporation",
"shortName": "DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0013 - Disclosure - INCOME TAXES",
"role": "http://entb.net/role/IncomeTaxes",
"shortName": "INCOME TAXES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubsequentEventsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0015 - Disclosure - SUBSEQUENT EVENTS",
"role": "http://entb.net/role/SubsequentEvents",
"shortName": "SUBSEQUENT EVENTS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubsequentEventsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
"role": "http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"us-gaap:EarningsPerSharePolicyTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
"role": "http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"us-gaap:EarningsPerSharePolicyTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"div",
"etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:ScheduleOfDisposionTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0018 - Disclosure - DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION (Tables)",
"role": "http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.Tables",
"shortName": "DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"div",
"etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:ScheduleOfDisposionTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:ScheduleOfIncomeTaxProvisionTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0019 - Disclosure - INCOME TAXES (Tables)",
"role": "http://entb.net/role/IncomeTaxesTables",
"shortName": "INCOME TAXES (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "etni:ScheduleOfIncomeTaxProvisionTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"us-gaap:CommonStockSharesIssued",
"us-gaap:CommonStockSharesOutstanding",
"us-gaap:CommonStockSharesOutstanding",
"span",
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockSharesIssued",
"reportCount": 1,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0020 - Disclosure - ORGANIZATION, DESCRIPTION OF BUSINESS, AND GOING CONCERN (Details Narrative)",
"role": "http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"shortName": "ORGANIZATION, DESCRIPTION OF BUSINESS, AND GOING CONCERN (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"p",
"div",
"us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_As_Of_15_Nov_2018T00_00_00_TO_15_Nov_2018T00_00_00_usgaapStatementClassOfStockAxis_usgaapRedeemableConvertiblePreferredStockMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_etniBuyerMember",
"decimals": "INF",
"lang": null,
"name": "us-gaap:PreferredStockSharesIssued",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Cash",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "0002 - Statement - CONDENSED BALANCE SHEETS",
"role": "http://entb.net/role/CONDENSEDBALANCESHEETS",
"shortName": "CONDENSED BALANCE SHEETS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"lang": null,
"name": "us-gaap:AssetsCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"tbody",
"table",
"us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"div",
"div",
"us-gaap:EarningsPerSharePolicyTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
"role": "http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"tbody",
"table",
"us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"div",
"div",
"us-gaap:EarningsPerSharePolicyTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"lang": null,
"name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Cash",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals)",
"role": "http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R22": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:DueToRelatedPartiesCurrent",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0023 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
"role": "http://entb.net/role/RelatedPartyTransactionsDetailsNarrative",
"shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130_srtTitleOfIndividualAxis_srtOfficerMember",
"decimals": "0",
"lang": null,
"name": "us-gaap:DueToRelatedPartiesCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R23": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "4",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unitRef": "USD_per_Share",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0024 - Disclosure - STOCKHOLDERS' EQUITY (Details Narrative)",
"role": "http://entb.net/role/StockholdersEquityDetailsNarrative",
"shortName": "STOCKHOLDERS' EQUITY (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20181001to20181002_usgaapStatementClassOfStockAxis_usgaapRedeemableConvertiblePreferredStockMember",
"decimals": null,
"lang": "en-US",
"name": "us-gaap:PreferredStockRedemptionTerms",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R24": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "4",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unitRef": "USD_per_Share",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0025 - Disclosure - DECONSOLIDATION OF ZANDER THERAPEUTICS, INC. (Details Narrative)",
"role": "http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"shortName": "DECONSOLIDATION OF ZANDER THERAPEUTICS, INC. (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"etni:DeconsolidationOfZanderTherapeuticsTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_3ME_01_Sep_2018T00_00_00_TO_30_Nov_2018T00_00_00_usgaapStatementEquityComponentsAxis_etniZanderMStockMember",
"decimals": "0",
"lang": null,
"name": "us-gaap:DeconsolidationGainOrLossAmount",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R25": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"div",
"etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_3ME_01_Sep_2018T00_00_00_TO_30_Nov_2018T00_00_00",
"decimals": "0",
"first": true,
"lang": null,
"name": "etni:DivestitureAmountOfConsiderationReceived",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0026 - Disclosure - DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION (Details)",
"role": "http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails",
"shortName": "DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"etni:ScheduleOfDisposionTextBlock",
"div",
"etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_3ME_01_Sep_2018T00_00_00_TO_30_Nov_2018T00_00_00_ConsolidatedEntitiesAxis_SubsidiariesMember",
"decimals": "0",
"lang": null,
"name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R26": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"div",
"etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_3ME_01_Sep_2018T00_00_00_TO_30_Nov_2018T00_00_00",
"decimals": "0",
"first": true,
"lang": null,
"name": "etni:DivestitureAmountOfConsiderationReceived",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0027 - Disclosure - DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION (Details Narrative)",
"role": "http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetailsNarrative",
"shortName": "DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"p",
"div",
"etni:DispositionOfEntestBiomedicalCaliforniaCorporation",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_As_Of_30_Nov_2018T00_00_00_TO_30_Nov_2018T00_00_00",
"decimals": "0",
"lang": null,
"name": "etni:FurnitureFixturesAndEquipmentCarryingAmount",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R27": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"tbody",
"table",
"us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"div",
"div",
"us-gaap:EarningsPerSharePolicyTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0028 - Disclosure - INCOME TAXES (Details)",
"role": "http://entb.net/role/IncomeTaxesDetails",
"shortName": "INCOME TAXES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"etni:ScheduleOfIncomeTaxProvisionTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "2",
"lang": null,
"name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"reportCount": 1,
"unique": true,
"unitRef": "pure",
"xsiNil": "false"
}
},
"R28": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0029 - Disclosure - INCOME TAXES (Details 1)",
"role": "http://entb.net/role/IncomeTaxesDetails1",
"shortName": "INCOME TAXES (Details 1)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R29": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"span",
"span",
"p",
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:OperatingLossCarryforwards",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0030 - Disclosure - INCOME TAXES (Details Narrative)",
"role": "http://entb.net/role/IncomeTaxesDetailsNarrative",
"shortName": "INCOME TAXES (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"span",
"span",
"span",
"span",
"p",
"us-gaap:IncomeTaxDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:OperatingLossCarryforwards",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"us-gaap:CommonStockSharesAuthorized",
"span",
"span",
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20191130",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockSharesAuthorized",
"reportCount": 1,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "0003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)",
"role": "http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"shortName": "CONDENSED BALANCE SHEETS (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": null
},
"R4": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "0004 - Statement - CONDENSED STATEMENTS OF OPERATIONS (unaudited)",
"role": "http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"shortName": "CONDENSED STATEMENTS OF OPERATIONS (unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"span",
"strong",
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_usgaapStatementEquityComponentsAxis_etniSeriesAAPreferredStockMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:SharesOutstanding",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "0005 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)",
"role": "http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"shortName": "CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"strong",
"span",
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "Context_As_Of_31_Aug_2018T00_00_00_TO_31_Aug_2018T00_00_00_usgaapStatementEquityComponentsAxis_etniSeriesAAPreferredStockMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:SharesOutstanding",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"tbody",
"table",
"us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"div",
"div",
"us-gaap:EarningsPerSharePolicyTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "0006 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (unaudited)",
"role": "http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited",
"shortName": "CONDENSED STATEMENTS OF CASH FLOWS (unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": "0",
"lang": null,
"name": "etni:NetCashReceivedForDivestiture",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0007 - Disclosure - ORGANIZATION, DESCRIPTION OF BUSINESS, AND GOING CONCERN",
"role": "http://entb.net/role/OrganizationAndDescriptionOfBusiness",
"shortName": "ORGANIZATION, DESCRIPTION OF BUSINESS, AND GOING CONCERN",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"role": "http://entb.net/role/SummaryOfSignificantAccountingPolicies",
"shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "0009 - Disclosure - RELATED PARTY TRANSACTIONS",
"role": "http://entb.net/role/RelatedPartyTransactions",
"shortName": "RELATED PARTY TRANSACTIONS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "etni-20191130.htm",
"contextRef": "C_20190901to20191130",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 17,
"tag": {
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
"label": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r156"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r157"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine2": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 2 such as Street or Suite number",
"label": "Entity Address, Address Line Two"
}
}
},
"localname": "EntityAddressAddressLine2",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCountry": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "ISO 3166-1 alpha-2 country code.",
"label": "Entity Address, Country"
}
}
},
"localname": "EntityAddressCountry",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "countryCodeItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity's Reporting Status Current"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityExTransitionPeriod": {
"auth_ref": [
"r160"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
"label": "Entity Ex Transition Period"
}
}
},
"localname": "EntityExTransitionPeriod",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r159"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r158"
],
"lang": {
"en-US": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "employerIdItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://entb.net/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"etni_AdjustmentToAdditionalPaidInCapitalContributedCapital": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount represent capital contribution.",
"label": "Contributed Capital",
"terseLabel": "Contributed Capital"
}
}
},
"localname": "AdjustmentToAdditionalPaidInCapitalContributedCapital",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_BuyerMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The member represent buyer of the stock.",
"label": "Peiwen Yu [Member]",
"terseLabel": "Peiwen Yu (the \"Buyer\")"
}
}
},
"localname": "BuyerMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_CommonStock1Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The member represent the common stock outstanding of the company.",
"label": "Common Stock And Non-Voting Convertible Preferred Stock [Member]",
"terseLabel": "Common stock and non-voting convertible preferred stock"
}
}
},
"localname": "CommonStock1Member",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_CommonStockDistributionDescription": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Description of common stock.",
"label": "Common Stock Distribution Description",
"verboseLabel": "Common stock distribution description"
}
}
},
"localname": "CommonStockDistributionDescription",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "stringItemType"
},
"etni_CommonStockRecordDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information related to common stock record date.",
"label": "Record date",
"terseLabel": "Record date"
}
}
},
"localname": "CommonStockRecordDate",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "dateItemType"
},
"etni_ConversionPriceEqualsAverageClosingBidPricePercent": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "One time right per agreement where percent of the average closing bid price equals conversion price.",
"label": "Conversion price equals average closing bid price (percent)",
"verboseLabel": "Conversion price equals average closing bid price (percent)"
}
}
},
"localname": "ConversionPriceEqualsAverageClosingBidPricePercent",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"etni_DebtSatsisfuedThroughCapitalContribution": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of debt satsisfued trough capital contribution.",
"label": "Debt Satisfied through Contributed Capital",
"terseLabel": "Debt Satisfied through Contributed Capital"
}
}
},
"localname": "DebtSatsisfuedThroughCapitalContribution",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_DeconsolidationOfZanderTherapeuticsIncAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Deconsolidation Of Zander Therapeutics Inc [Abstract]"
}
}
},
"localname": "DeconsolidationOfZanderTherapeuticsIncAbstract",
"nsuri": "http://entb.net/20191130",
"xbrltype": "stringItemType"
},
"etni_DeconsolidationOfZanderTherapeuticsTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents textblock of deconsilation of Zander therapeutics.",
"label": "DECONSOLIDATION OF ZANDER THERAPEUTICS, INC."
}
}
},
"localname": "DeconsolidationOfZanderTherapeuticsTextBlock",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc."
],
"xbrltype": "textBlockItemType"
},
"etni_DecreaseInCarryingValue": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of decrease in carrying value.",
"label": "Carrying value",
"terseLabel": "Carrying value"
}
}
},
"localname": "DecreaseInCarryingValue",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"etni_DescriptionOfCarryforwardsExpiration1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Description of carryforwards expiration.",
"label": "Description of carry forwards expiry year"
}
}
},
"localname": "DescriptionOfCarryforwardsExpiration1",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"etni_DispositionOfEntestBiomedicalCaliforniaCorporation": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Entire Disclosure is representing information about disposition of Entest Biomedical California Corporation by entity.",
"label": "DISPOSITION OF ENTEST BIOMEDICAL, INC., A CALIFORNIA CORPORATION"
}
}
},
"localname": "DispositionOfEntestBiomedicalCaliforniaCorporation",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporation"
],
"xbrltype": "textBlockItemType"
},
"etni_DispositionOfEntestBiomedicalInc.CaliforniaCorporationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Disposition Of Entest Biomedical Inc. California Corporation"
}
}
},
"localname": "DispositionOfEntestBiomedicalInc.CaliforniaCorporationAbstract",
"nsuri": "http://entb.net/20191130",
"xbrltype": "stringItemType"
},
"etni_DivestitureAmountOfConsiderationReceived": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of divestiture amount of consideration received.",
"label": "DivestitureAmountOfConsiderationReceived",
"negatedLabel": "Divestiture consideration",
"negatedTerseLabel": "Consideration Received in Divestiture"
}
}
},
"localname": "DivestitureAmountOfConsiderationReceived",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails",
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"etni_DivestitureOfBusinessesAccruedRentReceivableDerecognizedInDivestiture": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Accrued rent receivable derecognized in divestiture.",
"label": "DivestitureOfBusinessesAccruedRentReceivableDerecognizedInDivestiture",
"negatedLabel": "Accrued Rent Receivable Derecognized in Divestiture"
}
}
},
"localname": "DivestitureOfBusinessesAccruedRentReceivableDerecognizedInDivestiture",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails"
],
"xbrltype": "monetaryItemType"
},
"etni_DocumentAndEntityInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Document And Entity Information"
}
}
},
"localname": "DocumentAndEntityInformationAbstract",
"nsuri": "http://entb.net/20191130",
"xbrltype": "stringItemType"
},
"etni_FurnitureFixturesAndEquipmentCarryingAmount": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents carrying amount of furniture, fixtures and equipment.",
"label": "Furniture Fixtures And Equipment Carrying Amount",
"terseLabel": "Furniture fixtures and equipment carrying amount"
}
}
},
"localname": "FurnitureFixturesAndEquipmentCarryingAmount",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"etni_GainOnWriteOfAccountsPayable": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents gain on write of accounts payable.",
"label": "Gain on write of accounts payable",
"verboseLabel": "Gain on write off of accounts payable"
}
}
},
"localname": "GainOnWriteOfAccountsPayable",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_GainOnWriteOffOfAccountsPayable": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 40.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of gain on write off of accounts payable.",
"label": "GainOnWriteOffOfAccountsPayable",
"negatedLabel": "Gain on write off of accounts payable"
}
}
},
"localname": "GainOnWriteOffOfAccountsPayable",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_IncomeTaxExpenseBeforeDeductionOfNetOperatingTaxCarryforwards": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/IncomeTaxesDetails": {
"order": 0.0,
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Income tax expense before deduction of net operating tax carryforwards.",
"label": "Income tax expense (benefit)",
"terseLabel": "Income tax expense (benefit)"
}
}
},
"localname": "IncomeTaxExpenseBeforeDeductionOfNetOperatingTaxCarryforwards",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"etni_IncomeTaxLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents income tax line items.",
"label": "Income Tax [Line Items]"
}
}
},
"localname": "IncomeTaxLineItems",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"etni_IncomeTaxTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents income tax table.",
"label": "Income Tax [Table]"
}
}
},
"localname": "IncomeTaxTable",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"etni_IncomeTaxesDetailsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Taxes"
}
}
},
"localname": "IncomeTaxesDetailsAbstract",
"nsuri": "http://entb.net/20191130",
"xbrltype": "stringItemType"
},
"etni_IncreaseDecreaseInAccruedRentalIncomeReceivable": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 50.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in related to accrued rental income receivable.",
"label": "Accrued rental income receivable",
"terseLabel": "Increase in accrued rental income receivable"
}
}
},
"localname": "IncreaseDecreaseInAccruedRentalIncomeReceivable",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_IncreaseDecreaseInUnearnedRent": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 70.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in related to unearned rent.",
"label": "Unearned rental income",
"verboseLabel": "Decrease in unearned rental income"
}
}
},
"localname": "IncreaseDecreaseInUnearnedRent",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_LiabilitiesDerecognizedInDivestitureOfBusinesses": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "It represent liabilities derecongnized in divestiture of businesses.",
"label": "Liabilities Derecognized in Divestiture",
"terseLabel": "Liabilities Derecognized in Divestiture"
}
}
},
"localname": "LiabilitiesDerecognizedInDivestitureOfBusinesses",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails"
],
"xbrltype": "monetaryItemType"
},
"etni_NetCashReceivedForDivestiture": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 30.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents amount related to net cash received for divestiture of Entest Biomedical.",
"label": "Net cash received for divestiture",
"terseLabel": "Net cash received for divestiture of Entest Biomedical"
}
}
},
"localname": "NetCashReceivedForDivestiture",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_NetOperatingTaxCarryforwards": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/IncomeTaxesDetails": {
"order": 10.0,
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Net operating tax carryforwards.",
"label": "Less: valuation allowance",
"negatedLabel": "Less: valuation allowance",
"verboseLabel": "Less: valuation allowance"
}
}
},
"localname": "NetOperatingTaxCarryforwards",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"etni_NotesToFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Notes to Financial Statements"
}
}
},
"localname": "NotesToFinancialStatementsAbstract",
"nsuri": "http://entb.net/20191130",
"xbrltype": "stringItemType"
},
"etni_NumberOfConsecutiveTradingDays": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of consecutive trading days.",
"label": "Number of consecutive trading days",
"terseLabel": "Number of consecutive trading days"
}
}
},
"localname": "NumberOfConsecutiveTradingDays",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "durationItemType"
},
"etni_PaymentsOfBankOverdraft": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cashout flow for payments of bank overdraft.",
"label": "PaymentsOfBankOverdraft",
"negatedLabel": "Repayment of bank overdraft"
}
}
},
"localname": "PaymentsOfBankOverdraft",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_PercentageOfStockOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The percentage of stock outstanding.",
"label": "Percentage of Stock outstanding",
"terseLabel": "Percentage of Stock outstanding"
}
}
},
"localname": "PercentageOfStockOutstanding",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"etni_ProceedsFromAdditionalPaidInCapital": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.",
"label": "Proceed additional paid in Capital",
"verboseLabel": "Contributed capital"
}
}
},
"localname": "ProceedsFromAdditionalPaidInCapital",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_RefundOnAmountPreviouslyPaid1": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 30.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents return on amount previously paid.",
"label": "Refund on amount previously paid",
"verboseLabel": "Refund on amount previously paid"
}
}
},
"localname": "RefundOnAmountPreviouslyPaid1",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"etni_ScheduleOfDisposionTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of disposion.",
"label": "Schedule of disposion"
}
}
},
"localname": "ScheduleOfDisposionTextBlock",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.Tables"
],
"xbrltype": "textBlockItemType"
},
"etni_ScheduleOfIncomeTaxProvisionTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of income tax provision table text block.",
"label": "Schedule of income tax provision"
}
}
},
"localname": "ScheduleOfIncomeTaxProvisionTableTextBlock",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/IncomeTaxesTables"
],
"xbrltype": "textBlockItemType"
},
"etni_SeriesAAAPreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable series AA preferred stock or outstanding series AA preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Series AAA [Member]",
"terseLabel": "Series AAA Preferred",
"verboseLabel": "Series AAA"
}
}
},
"localname": "SeriesAAAPreferredStockMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_SeriesAAPreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable series AA preferred stock or outstanding series AA preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Series AA [Member]",
"terseLabel": "Series AA"
}
}
},
"localname": "SeriesAAPreferredStockMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_StockPurchaseAgreementMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The member represent stock purchase agreement.",
"label": "Stock Purchase Agreement [Member]",
"terseLabel": "Stock purchase agreement (the \"SPA\"),"
}
}
},
"localname": "StockPurchaseAgreementMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_UnearnedRentalPayments": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents information related to unearned rental payments.",
"label": "Unearned rental payments",
"terseLabel": "Unearned rental payments"
}
}
},
"localname": "UnearnedRentalPayments",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"etni_VotingStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The member represent the voting stock of the company.",
"label": "Voting Common Stock [Member]",
"terseLabel": "Voting common stock"
}
}
},
"localname": "VotingStockMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_ZanderMStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The member represent zander m stock.",
"label": "Zander M Stock [Member]",
"terseLabel": "Zander M stock"
}
}
},
"localname": "ZanderMStockMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "domainItemType"
},
"etni_ZanderMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The member represent zander.",
"label": "Zander [Member]",
"terseLabel": "Zander Therapeutics, Inc."
}
}
},
"localname": "ZanderMember",
"nsuri": "http://entb.net/20191130",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_ConsolidatedEntitiesAxis": {
"auth_ref": [
"r155"
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Entities [Axis]"
}
}
},
"localname": "ConsolidatedEntitiesAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails"
],
"xbrltype": "stringItemType"
},
"srt_ConsolidatedEntitiesDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Entities [Domain]"
}
}
},
"localname": "ConsolidatedEntitiesDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails"
],
"xbrltype": "domainItemType"
},
"srt_OfficerMember": {
"auth_ref": [
"r85"
],
"lang": {
"en-US": {
"role": {
"label": "Officer [Member]",
"terseLabel": "Officer"
}
}
},
"localname": "OfficerMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://entb.net/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_SubsidiariesMember": {
"auth_ref": [
"r93",
"r123",
"r125"
],
"lang": {
"en-US": {
"role": {
"label": "Entest Biomedical, Inc. [Member]",
"terseLabel": "Entest Biomedical, Inc."
}
}
},
"localname": "SubsidiariesMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails"
],
"xbrltype": "domainItemType"
},
"srt_TitleOfIndividualAxis": {
"auth_ref": [
"r85",
"r124"
],
"lang": {
"en-US": {
"role": {
"label": "Title of Individual [Axis]"
}
}
},
"localname": "TitleOfIndividualAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://entb.net/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"srt_TitleOfIndividualWithRelationshipToEntityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Title of Individual [Domain]"
}
}
},
"localname": "TitleOfIndividualWithRelationshipToEntityDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://entb.net/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"auth_ref": [
"r15"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 0.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Accounts payable and accrued expenses",
"verboseLabel": "Accounts payable and accrued expenses"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
"auth_ref": [
"r21",
"r22",
"r23",
"r116"
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
"label": "Accumulated Other Comprehensive Income(Loss) [Member]",
"terseLabel": "Accumulated Other Comprehensive Income (Loss)"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdditionalPaidInCapital": {
"auth_ref": [
"r8"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 20.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
"label": "Additional Paid in Capital",
"verboseLabel": "Additional paid in capital"
}
}
},
"localname": "AdditionalPaidInCapital",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-In Capital [Member]",
"terseLabel": "Additional Paid In Capital"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:",
"verboseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
"label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
}
}
},
"localname": "ArrangementsAndNonarrangementTransactionsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r83",
"r140",
"r145"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "Total Assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "ASSETS",
"verboseLabel": "Assets"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r2",
"r3",
"r20"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 0.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total Current Assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Current Assets",
"verboseLabel": "Current Assets"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "Basis of Presentation"
}
}
},
"localname": "BasisOfAccountingPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Cash": {
"auth_ref": [
"r13",
"r150",
"r151"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 0.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash",
"periodEndLabel": "Cash, Ending Balance",
"periodStartLabel": "Cash, Beginning Balance",
"terseLabel": "Cash and cash equivalents",
"totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
"verboseLabel": "Cash"
}
}
},
"localname": "Cash",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsAtCarryingValue": {
"auth_ref": [
"r1",
"r13",
"r44"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash and Cash Equivalents, at Carrying Value",
"periodEndLabel": "Cash at End of Period",
"periodStartLabel": "Cash at Beginning of Period",
"verboseLabel": "Cash and cash equivalents"
}
}
},
"localname": "CashAndCashEquivalentsAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.",
"label": "Cash and Cash Equivalents, Period Increase (Decrease)",
"totalLabel": "Net increase (decrease) in cash"
}
}
},
"localname": "CashAndCashEquivalentsPeriodIncreaseDecrease",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
"auth_ref": [
"r4",
"r45",
"r47"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
"label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
"verboseLabel": "Cash and Cash Equivalents"
}
}
},
"localname": "CashAndCashEquivalentsPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Supplemental disclosure of non-cash financing activity",
"verboseLabel": "Supplemental Disclosure of Non-Cash Financing Activity:"
}
}
},
"localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfStockDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
"label": "Class of Stock [Domain]"
}
}
},
"localname": "ClassOfStockDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]",
"terseLabel": "Common Stock"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r7"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common stock, par value",
"verboseLabel": "Common stock, par value"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r7"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common stock, authorized",
"verboseLabel": "Common stock, authorized"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r7"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common stock, issued",
"terseLabel": "Common stock, issued",
"verboseLabel": "Number of common stock issued"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r7",
"r89"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common stock, outstanding",
"verboseLabel": "Common stock, shares outstanding"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r7"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 10.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common stock- 500,000,000 shares authorized; $0.0001 par value 49,170,472 shares issued and outstanding",
"verboseLabel": "Common stock: 500,000,000 shares authorized; $0.0001 par value 49,171,083 shares issued and outstanding"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CostsAndExpenses": {
"auth_ref": [
"r31"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total costs of sales and operating expenses for the period.",
"label": "Costs and Expenses",
"totalLabel": "Total operating expenses"
}
}
},
"localname": "CostsAndExpenses",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CostsAndExpensesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Operating Expenses:",
"terseLabel": "Operating expenses:"
}
}
},
"localname": "CostsAndExpensesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_DeconsolidationGainOrLossAmount": {
"auth_ref": [
"r117"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.",
"label": "Gain on deconsolidation",
"terseLabel": "Gain on deconsolidation"
}
}
},
"localname": "DeconsolidationGainOrLossAmount",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredTaxAssetsNet": {
"auth_ref": [
"r102"
],
"calculation": {
"http://entb.net/role/IncomeTaxesDetails1": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
"label": "Deferred Tax Assets, Net of Valuation Allowance",
"totalLabel": "Net deferred tax asset"
}
}
},
"localname": "DeferredTaxAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails1"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
"auth_ref": [
"r94",
"r107",
"r108"
],
"calculation": {
"http://entb.net/role/IncomeTaxesDetails1": {
"order": 0.0,
"parentTag": "us-gaap_DeferredTaxAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
"label": "Net operating tax carry forwards",
"terseLabel": "Net operating loss carryforwards",
"verboseLabel": "Deferred tax asset"
}
}
},
"localname": "DeferredTaxAssetsOperatingLossCarryforwards",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails1"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredTaxAssetsValuationAllowance": {
"auth_ref": [
"r103"
],
"calculation": {
"http://entb.net/role/IncomeTaxesDetails1": {
"order": 10.0,
"parentTag": "us-gaap_DeferredTaxAssetsNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
"label": "Deferred Tax Assets, Valuation Allowance",
"negatedLabel": "Valuation allowance"
}
}
},
"localname": "DeferredTaxAssetsValuationAllowance",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails1"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DueToRelatedPartiesCurrent": {
"auth_ref": [
"r14",
"r50",
"r122"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 10.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Due to related party",
"terseLabel": "Due to related party"
}
}
},
"localname": "DueToRelatedPartiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EarliestTaxYearMember": {
"auth_ref": [
"r99"
],
"lang": {
"en-US": {
"role": {
"documentation": "Earliest identified tax year.",
"label": "Earliest Tax Year [Member]",
"terseLabel": "Previous Tax Year"
}
}
},
"localname": "EarliestTaxYearMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_EarningsPerShareBasic": {
"auth_ref": [
"r30",
"r52",
"r57",
"r61",
"r62",
"r65",
"r70",
"r143",
"r149"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
"label": "Basic income (loss) per common share (in dollars per share)",
"terseLabel": "Basic",
"verboseLabel": "Basic income (loss) per common share (in dollars per share)"
}
}
},
"localname": "EarningsPerShareBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareBasicAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Numerator:"
}
}
},
"localname": "EarningsPerShareBasicAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Weighted average number of common shares outstanding",
"verboseLabel": "Net income (loss) per common share:"
}
}
},
"localname": "EarningsPerShareBasicAndDilutedAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareDiluted": {
"auth_ref": [
"r30",
"r52",
"r57",
"r61",
"r62",
"r65",
"r70",
"r143",
"r149"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Diluted income (loss) per common share (in dollars per share)",
"terseLabel": "Diluted income (loss) per common share (in dollars per share)",
"verboseLabel": "Diluted"
}
}
},
"localname": "EarningsPerShareDiluted",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerSharePolicyTextBlock": {
"auth_ref": [
"r47",
"r66",
"r67",
"r68"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
"label": "Earnings Per Share, Policy [Policy Text Block]",
"terseLabel": "Basic and Diluted Net Income (Loss) per Common Share"
}
}
},
"localname": "EarningsPerSharePolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
"auth_ref": [
"r49",
"r97",
"r98"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Effective tax rate"
}
}
},
"localname": "EffectiveIncomeTaxRateContinuingOperations",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
"auth_ref": [
"r97",
"r98",
"r109"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
"label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
"verboseLabel": "Effective interest tax rate"
}
}
},
"localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_EquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Equity [Abstract]"
}
}
},
"localname": "EquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r89"
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
"label": "Equity Component [Domain]"
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityMethodInvestmentOwnershipPercentage": {
"auth_ref": [
"r87"
],
"lang": {
"en-US": {
"role": {
"documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
"label": "Ownership Percentage",
"verboseLabel": "Ownership percentage"
}
}
},
"localname": "EquityMethodInvestmentOwnershipPercentage",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
"label": "Fair Value Measurement, Policy [Policy Text Block]",
"verboseLabel": "Fair Value Measurements"
}
}
},
"localname": "FairValueMeasurementPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GainLossOnDispositionOfAssets1": {
"auth_ref": [
"r42"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
},
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 50.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
"label": "Gain (Loss) on Disposition of Assets",
"negatedLabel": "Loss on disposition Entest Biomedical",
"negatedTotalLabel": "Loss Recognized in Divestiture",
"positiveTerseLabel": "Loss on disposition Entest Biomedical",
"terseLabel": "Loss recognized in divestiture",
"totalLabel": "Loss Recognized in Divestiture",
"verboseLabel": "Loss on disposition Entest Biomedical"
}
}
},
"localname": "GainLossOnDispositionOfAssets1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited",
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails",
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GainLossOnSaleOfBusiness": {
"auth_ref": [
"r42",
"r117"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 20.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
},
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 20.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
"label": "Gain on disposition of Zander",
"negatedLabel": "Gain on disposition of Zander",
"terseLabel": "Gain on disposition of Zander",
"totalLabel": "Loss Recognized in Divestiture",
"verboseLabel": "Loss on disposition"
}
}
},
"localname": "GainLossOnSaleOfBusiness",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited",
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GeneralAndAdministrativeExpense": {
"auth_ref": [
"r32"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
"label": "General and administration",
"verboseLabel": "General and administration"
}
}
},
"localname": "GeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncentiveDistributionDate": {
"auth_ref": [
"r63",
"r64",
"r69"
],
"lang": {
"en-US": {
"role": {
"documentation": "Date the limited liability company (LLC) managing member or a limited partnership (LP) general partner receives payment of an incentive obligation in cash, stock or units, in CCYY-MM-DD format.",
"label": "Distribution Date",
"verboseLabel": "Distribution date"
}
}
},
"localname": "IncentiveDistributionDate",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "dateItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Tax Disclosure [Abstract]"
}
}
},
"localname": "IncomeTaxDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxDisclosureTextBlock": {
"auth_ref": [
"r112"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
"label": "INCOME TAXES"
}
}
},
"localname": "IncomeTaxDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxes"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r48",
"r82",
"r110"
],
"calculation": {
"http://entb.net/role/IncomeTaxesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income Tax Expense (Benefit)",
"terseLabel": "Income tax provision",
"totalLabel": "Income tax expense (benefit)",
"verboseLabel": "Income tax provision"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeTaxPolicyTextBlock": {
"auth_ref": [
"r26",
"r47",
"r95",
"r96",
"r100",
"r101",
"r105",
"r111",
"r154"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
"label": "Income Tax, Policy [Policy Text Block]",
"verboseLabel": "Income Taxes"
}
}
},
"localname": "IncomeTaxPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncomeTaxesPaid": {
"auth_ref": [
"r39",
"r46"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
"label": "Income tax provision",
"terseLabel": "Income tax provision",
"verboseLabel": "Cash paid for taxes"
}
}
},
"localname": "IncomeTaxesPaid",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r41"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 60.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
"label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
"verboseLabel": "Increase in accounts payable and accrued expenses"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Changes in operating assets and liabilities:",
"terseLabel": "Changes in operating assets and liabilities:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
"auth_ref": [
"r59",
"r67"
],
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
"label": "Dilutive effect of convertible instruments"
}
}
},
"localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_InterestExpense": {
"auth_ref": [
"r27",
"r81",
"r120",
"r121",
"r144"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 40.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
"label": "Interest Expense",
"negatedLabel": "Interest expense"
}
}
},
"localname": "InterestExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestPaidNet": {
"auth_ref": [
"r36",
"r38",
"r46"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
"label": "Cash paid for interest",
"verboseLabel": "Cash paid for interest"
}
}
},
"localname": "InterestPaidNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestReceivable": {
"auth_ref": [
"r19"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
"label": "Accrued Interest Receivable",
"terseLabel": "Accrued Interest Receivable",
"verboseLabel": "Interest accrued"
}
}
},
"localname": "InterestReceivable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LatestTaxYearMember": {
"auth_ref": [
"r99"
],
"lang": {
"en-US": {
"role": {
"documentation": "Latest identified tax year.",
"label": "Latest Tax Year [Member]",
"verboseLabel": "Current Tax Year"
}
}
},
"localname": "LatestTaxYearMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r16"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 0.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Total Liabilities"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r12",
"r141",
"r147"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "Total liabilities and Stockholder's Deficit"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities And Stockholders' Deficit",
"verboseLabel": "Liabilities And Stockholders' Deficit"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r17"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 0.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"totalLabel": "Total Current Liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Current Liabilities",
"verboseLabel": "Current Liabilities"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r37"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Cash Flows From Financing Activities:",
"terseLabel": "Cash Flows From Financing Activities:"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r37",
"r40",
"r43"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net cash used in operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Cash Flows From Operating Activities:",
"terseLabel": "Cash Flows from Operating Activities:"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r24",
"r25",
"r29",
"r43",
"r67",
"r142",
"r148"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net Income (Loss) Attributable to Parent",
"terseLabel": "Net income (loss) for the period",
"totalLabel": "Net income (loss)",
"verboseLabel": "Net income (loss)"
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/IncomeTaxesDetails",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
"auth_ref": [
"r52",
"r55"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
"label": "Income (loss) available to common stockholders"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
"label": "Recent Accounting Pronouncements"
}
}
},
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NoncontrollingInterestMember": {
"auth_ref": [
"r114"
],
"lang": {
"en-US": {
"role": {
"documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
"label": "Non-Controlling Interest In Subsidiary [Member]",
"terseLabel": "Non-Controlling Interest In Subsidiary"
}
}
},
"localname": "NoncontrollingInterestMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_NonoperatingIncomeExpense": {
"auth_ref": [
"r33"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
"label": "Nonoperating Income (Expense)",
"totalLabel": "Total Other Income (Expense)"
}
}
},
"localname": "NonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NonoperatingIncomeExpenseAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Income (Expense):",
"verboseLabel": "Other income (expense):"
}
}
},
"localname": "NonoperatingIncomeExpenseAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingIncomeLoss": {
"auth_ref": [
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net result for the period of deducting operating expenses from operating revenues.",
"label": "Operating Income (Loss)",
"totalLabel": "Operating loss"
}
}
},
"localname": "OperatingIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLossCarryforwards": {
"auth_ref": [
"r106"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
"label": "Operating Loss Carryforwards",
"terseLabel": "Net operating loss carry forwards"
}
}
},
"localname": "OperatingLossCarryforwards",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
"auth_ref": [
"r51",
"r53",
"r78",
"r119"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
"label": "ORGANIZATION, DESCRIPTION OF BUSINESS, AND GOING CONCERN"
}
}
},
"localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/OrganizationAndDescriptionOfBusiness"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": {
"auth_ref": [
"r60"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
"label": "Earnings allocated to participating securities"
}
}
},
"localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PreferredStockConvertibleConversionPriceIncrease": {
"auth_ref": [
"r90"
],
"lang": {
"en-US": {
"role": {
"documentation": "Per share increase in conversion price of convertible preferred stock. Excludes change due to standard antidilution provision.",
"label": "Conversion price reduction due to closing bid price (in dollar per share)",
"terseLabel": "Conversion price reduction due to closing bid price (in dollar per share)"
}
}
},
"localname": "PreferredStockConvertibleConversionPriceIncrease",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r6"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Preferred stock, par value",
"terseLabel": "Preferred stock, par value"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockRedemptionTerms": {
"auth_ref": [
"r88",
"r90"
],
"lang": {
"en-US": {
"role": {
"documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.",
"label": "Liquidation terms",
"terseLabel": "Liquidation terms"
}
}
},
"localname": "PreferredStockRedemptionTerms",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r6"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Preferred stock, authorized",
"verboseLabel": "Preferred stock, authorized"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesIssued": {
"auth_ref": [
"r6"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
"label": "Preferred stock, issued",
"terseLabel": "Preferred stock, issued",
"verboseLabel": "Number of preferred stock issued"
}
}
},
"localname": "PreferredStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r6"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Preferred stock, outstanding",
"verboseLabel": "Preferred stock, shares outstanding"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockValue": {
"auth_ref": [
"r6"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 0.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Preferred Stock"
}
}
},
"localname": "PreferredStockValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
"auth_ref": [
"r0"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.",
"label": "Reclassifications"
}
}
},
"localname": "PriorPeriodReclassificationAdjustmentDescription",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
"auth_ref": [
"r34"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
"label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
"negatedLabel": "Cash derecognized in Divestiture"
}
}
},
"localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromRelatedPartyDebt": {
"auth_ref": [
"r35"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited": {
"order": 20.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
"label": "Proceeds from Related Party Debt",
"verboseLabel": "Proceeds from related parties"
}
}
},
"localname": "ProceedsFromRelatedPartyDebt",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProfessionalFees": {
"auth_ref": [
"r152",
"r153"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
"label": "Professional fees",
"terseLabel": "Professional fees"
}
}
},
"localname": "ProfessionalFees",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RedeemableConvertiblePreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
"label": "Redeemable Convertible Preferred Stock [Member]",
"terseLabel": "Non-Voting Convertible Preferred Stock",
"verboseLabel": "Non-Voting"
}
}
},
"localname": "RedeemableConvertiblePreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyDomain": {
"auth_ref": [
"r126"
],
"lang": {
"en-US": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party [Domain]"
}
}
},
"localname": "RelatedPartyDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Related Party Transactions [Abstract]"
}
}
},
"localname": "RelatedPartyTransactionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"auth_ref": [
"r93",
"r123",
"r125",
"r128",
"r129",
"r130",
"r131",
"r132",
"r133",
"r134",
"r135",
"r136",
"r137",
"r138",
"r139"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party [Axis]"
}
}
},
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"auth_ref": [
"r126"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "RELATED PARTY TRANSACTIONS"
}
}
},
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/RelatedPartyTransactions"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RentalIncomeNonoperating": {
"auth_ref": [
"r33"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Income earned by providing the use of assets to an outside party in exchange for a payment or series of payments that is nonoperating in nature.",
"label": "Rental income",
"verboseLabel": "Rental income"
}
}
},
"localname": "RentalIncomeNonoperating",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r9",
"r91",
"r146"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 30.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Accumulated Deficit",
"verboseLabel": "Accumulated deficit"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Accumulated Deficit [Member]",
"terseLabel": "Accumulated Deficit"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_Revenues": {
"auth_ref": [
"r28",
"r79",
"r80",
"r84"
],
"calculation": {
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited": {
"order": 0.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
"label": "Revenue",
"verboseLabel": "Revenue"
}
}
},
"localname": "Revenues",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
"auth_ref": [
"r104"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
"label": "Schedule of deferred tax assets"
}
}
},
"localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": {
"auth_ref": [
"r57",
"r58",
"r65",
"r70"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.",
"label": "Schedule of earnings per share"
}
}
},
"localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SeriesBPreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Series B Preferred Stock [Member]",
"terseLabel": "Series B"
}
}
},
"localname": "SeriesBPreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_SharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
"label": "Shares, Outstanding",
"periodEndLabel": "Ending balance, Shares",
"periodStartLabel": "Beginning balance, Shares"
}
}
},
"localname": "SharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "sharesItemType"
},
"us-gaap_SignificantAccountingPoliciesTextBlock": {
"auth_ref": [
"r51"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
"label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
}
}
},
"localname": "SignificantAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_StatementClassOfStockAxis": {
"auth_ref": [
"r5",
"r6",
"r7",
"r89"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by the different classes of stock of the entity.",
"label": "Class of Stock [Axis]"
}
}
},
"localname": "StatementClassOfStockAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r18",
"r89"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/RelatedPartyTransactionsDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Financial Position [Abstract]"
}
}
},
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Stockholders' Equity [Abstract]"
}
}
},
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS",
"http://entb.net/role/CONDENSEDBALANCESHEETSParenthetical",
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited",
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative",
"http://entb.net/role/DispositionOfEntestBiomedicalInc.CaliforniaCorporationDetails",
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative",
"http://entb.net/role/RelatedPartyTransactionsDetailsNarrative",
"http://entb.net/role/StockholdersEquityDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockDividendsShares": {
"auth_ref": [
"r89"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.",
"label": "Dividend in kind",
"terseLabel": "Dividend in kind"
}
}
},
"localname": "StockDividendsShares",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueNewIssues": {
"auth_ref": [
"r6",
"r7",
"r89",
"r91"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
"label": "Purchase price",
"verboseLabel": "Purchase price"
}
}
},
"localname": "StockIssuedDuringPeriodValueNewIssues",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r7",
"r10",
"r11",
"r86"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"periodEndLabel": "Ending balance, Amount",
"periodStartLabel": "Beginning balance, Amount"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSDEFICITUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Deficit",
"verboseLabel": "Stockholders' Deficit"
}
}
},
"localname": "StockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r114",
"r115",
"r118"
],
"calculation": {
"http://entb.net/role/CONDENSEDBALANCESHEETS": {
"order": 10.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
"label": "Total Stockholders' Deficit",
"totalLabel": "Total Stockholders' Deficit"
}
}
},
"localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDBALANCESHEETS"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"auth_ref": [
"r92"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
"label": "STOCKHOLDERS' EQUITY"
}
}
},
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/StockholdersEquity"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsequentEventsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Subsequent Events [Abstract]"
}
}
},
"localname": "SubsequentEventsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventsTextBlock": {
"auth_ref": [
"r127"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
"label": "SUBSEQUENT EVENTS"
}
}
},
"localname": "SubsequentEventsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SubsequentEvents"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cumulative number of shares issued or sold by the subsidiary or equity method investee on all stock transactions.",
"label": "Equity Method stock remaining",
"terseLabel": "Equity method stock remaining"
}
}
},
"localname": "SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/DeconsolidationOfZanderTherapeuticsInc.DetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Supplemental Cash Flow Information:",
"terseLabel": "Supplemental Cash Flow Information:"
}
}
},
"localname": "SupplementalCashFlowInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFCASHFLOWSUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_TaxPeriodAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information about the period subject to enacted tax laws.",
"label": "Tax Period [Axis]"
}
}
},
"localname": "TaxPeriodAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_TaxPeriodDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Identified tax period.",
"label": "Tax Period [Domain]"
}
}
},
"localname": "TaxPeriodDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/IncomeTaxesDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_TypeOfArrangementAxis": {
"auth_ref": [
"r113"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
"label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
}
}
},
"localname": "TypeOfArrangementAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/OrganizationDescriptionOfBusinessAndGoingConcernDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_UseOfEstimates": {
"auth_ref": [
"r71",
"r72",
"r73",
"r74",
"r75",
"r76",
"r77"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
"label": "Use of Estimates, Policy [Policy Text Block]",
"verboseLabel": "Use of Estimates"
}
}
},
"localname": "UseOfEstimates",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r56",
"r65"
],
"lang": {
"en-US": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Diluted (in shares)",
"terseLabel": "Diluted (in shares)",
"verboseLabel": "Diluted weighted-average of common stock"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r54",
"r65"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Basic (in shares)",
"terseLabel": "Basic (in shares)",
"verboseLabel": "Weighted-average shares of common stock"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/CONDENSEDSTATEMENTSOFOPERATIONSUnaudited",
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Denominator:"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://entb.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
],
"xbrltype": "stringItemType"
}
},
"unitCount": 4
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b),(c)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "30",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
},
"r112": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "740",
"URI": "http://asc.fasb.org/topic&trid=2144680"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "808",
"URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c),(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "4I",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
},
"r119": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "810",
"URI": "http://asc.fasb.org/topic&trid=2197479"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
},
"r121": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r126": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "850",
"URI": "http://asc.fasb.org/topic&trid=2122745"
},
"r127": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "855",
"URI": "http://asc.fasb.org/topic&trid=2122774"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.1)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(1)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(2)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04.9)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(19))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "210",
"Topic": "946",
"URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "210",
"Topic": "946",
"URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "220",
"Subparagraph": "(k)",
"Topic": "946",
"URI": "http://asc.fasb.org/extlink&oid=118262090&loc=SL114874205-224268"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
"Topic": "946",
"URI": "http://asc.fasb.org/extlink&oid=116637345&loc=SL114874292-224272"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "740",
"Topic": "954",
"URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Footnote 4))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
},
"r156": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-13"
},
"r157": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1-"
},
"r158": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r159": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r160": {
"Name": "Securities Act",
"Number": "7A",
"Publisher": "SEC",
"Section": "B",
"Subsection": "2"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.8)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r2": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "14A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "17B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(210.5-03(11))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(1))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r3": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(21))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(h)(2))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(27))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(k)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r51": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r53": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "250",
"URI": "http://asc.fasb.org/topic&trid=2122394"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1930-109256"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "72",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6926462&loc=SL5163672-159010"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "73",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6926462&loc=SL5163674-159010"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "103",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=109243028&loc=SL5199526-159011"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r78": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "275",
"URI": "http://asc.fasb.org/topic&trid=2134479"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21564-112644"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
},
"r92": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "http://asc.fasb.org/topic&trid=2208762"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(n)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
}
},
"version": "2.1"
} |
